Please use this identifier to cite or link to this item:
https://dspace.ctu.edu.vn/jspui/handle/123456789/109363
Title: | Synthesis, characterization and biological studies of novel copper(II) and Ni(II) complexes and triphenylphosphine |
Authors: | Elaaraj, Ibtissam Bouymajane, Aziz Raouan, Safae Er Nakkabi, Asmae Oulidi, Oumayma Filali, Fouzia Rhazi Cacciolas, Francesco Moualij, Noureddine El Fahim, Mohammed |
Keywords: | Bi-trinuclear complexes 2,2-diphenyl-1-picrylhydrazyl Germination index Lepidium sativum seeds Leukocyte nuclei Ligand |
Issue Date: | 2024 |
Series/Report no.: | Vietnam journal of Chemitry;Vol.62, Iss.04 .- P.527-539 |
Abstract: | Four new complexes of transition metals CuL₂, Ni₂L₂ (-Cl)₂, Cu₂(LH) 2P(Ph)₃(H₂O)(4-Cl)₂, [NI(LH)P(Ph)₃ Cl₂ (H₂O)] H₂O, based on the ligand [2- (benzo[d]thiazol-2-yl)phenol] (L) were synthesized and characterized by FTIR, NMR (¹H,¹³, ³¹C, ³¹P), ESI-MS and UV-visible spectroscopy. Spectral data show that the Cul₂ complex has a distorted square geometry, octahedral for the Cu₂(LH)2P(Ph)₃(H₂O) (µ-Cl)₂ [Ni(LH)P(Ph)₃Cl₂(H₂O)]H₂O complexes and tetrahedral for the Ni₂L₂(µ-Cl)₂ complex. Remarkable antioxidant and antibacterial activity against four strains for the complexes and ligand L was investigated. Cytotoxicity study was made on the germination of Lepidium sativum seeds, and on the behavior of erythrocytes and leukocyte nuclei. All synthesized products showed no hemolytic and genotoxic effects on erythrocytes and leukocyte nuclei, respectively. The results of the present study indicate that the synthesized ligand and its complexes tested are safe to human blood cells, and they might be used as active agents for pre-clinical trials. |
URI: | https://dspace.ctu.edu.vn/jspui/handle/123456789/109363 |
ISSN: | 2525-2321 |
Appears in Collections: | Vietnam Journal of Chemistry |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
_file_ Restricted Access | 4.98 MB | Adobe PDF | ||
Your IP: 3.22.242.169 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.